STE — Steris Income Statement

0.000.00%

Last trade - 00:00

HealthcareBalancedLarge CapHigh Flyer

Annual income statement for Steris, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	R2020 March 31st	2021 March 31st	R2022 March 31st	R2023 March 31st	2024 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	3,031	3,108	4,223	4,536	5,139
Cost of Revenue
Gross Profit	1,320	1,343	1,883	1,981	2,218
Selling / General / Administrative Expenses
Research And Development
Unusual Expense / Income
Total Operating Expenses	2,494	2,559	3,746	3,745	4,303
Operating Profit	537	548	478	791	836
Total Net Non Operating Interest Income / Expense
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	499	518	367	680	703
Provision for Income Taxes
Net Income After Taxes	408	397	284	556	553
Minority Interest
Net Income Before Extraordinary Items
Extraordinary Items
Net Income	408	397	244	107	378
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Diluted Net Income	408	397	244	107	378
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	4.93	5.18	4.91	5.85	6.2
Dividends per Share